Overview of Immunodeficiency Disorders

Immunology and Allergy Clinics of North America

Volumn 35, Issue 4, 2015, Pages 599-623

  Raje, Nikita ^a   Dinakar, Chitra ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

Antibody deficiency; Autoimmunity; Immune defect; Immune dysregulation; Immunodeficiency; Innate immune defect; Lymphoproliferation

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INFLUENZA VACCINE; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 4; MYELOID DIFFERENTIATION FACTOR 88; PEGADEMASE; RITUXIMAB;

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; AUTOIMMUNITY; BACTERIAL INFECTION; CINCA SYNDROME; COMBINED IMMUNODEFICIENCY; COMMON VARIABLE IMMUNODEFICIENCY; COMPLEMENT DEFICIENCY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; HAND WASHING; HEMOPHAGOCYTIC SYNDROME; HERPES SIMPLEX ENCEPHALITIS; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOHIDROTIC ECTODERMAL DYSPLASIA; IMMUNE DEFICIENCY; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOTHERAPY; INFECTION PREVENTION; INFLUENZA; INNATE IMMUNITY; IPEX SYNDROME; LIFESTYLE MODIFICATION; LUNG GRANULOMA; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MEDICAL HISTORY; MEDICATION COMPLIANCE; MOLECULAR DIAGNOSIS; NATURAL KILLER CELL; PHAGOCYTE DYSFUNCTION; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SCREENING TEST; SEVERE COMBINED IMMUNODEFICIENCY; VIRAL GENE THERAPY; ANIMAL; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; SIGNAL TRANSDUCTION;

ANIMALS; AUTOIMMUNITY; HUMANS; IMMUNITY; IMMUNOLOGIC DEFICIENCY SYNDROMES; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 84943818607     PISSN: 08898561     EISSN: 15578607     Source Type: Journal    
DOI: 10.1016/j.iac.2015.07.001     Document Type: Review

References (50)

1. Ochs H.D., Hitzig W.H. History of primary immunodeficiency diseases. Curr Opin Allergy Clin Immunol 2012, 12(6):577-587.
2. Al-Herz W., Bousfiha A., Casanova J.L., et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 2014, 5:162.
3. Yel L. Selective IgA deficiency. J Clin Immunol 2010, 30(1):10-16.
4. Kwan A., Abraham R.S., Currier R., et al. Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 2014, 312(7):729-738.
5. Routes J., Abinun M., Al-Herz W., et al. ICON: the early diagnosis of congenital immunodeficiencies. J Clin Immunol 2014, 34(4):398-424.
6. Grumach A.S., Kirschfink M. Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach. Mol Immunol 2014, 61(2):110-117.
7. Picard C., Casanova J.L., Puel A. Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev 2011, 24(3):490-497.
8. Pannicke U., Baumann B., Fuchs S., et al. Deficiency of innate and acquired immunity caused by an IKBKB mutation. N Engl J Med 2013, 369(26):2504-2514.
9. Frazao J.B., Errante P.R., Condino-Neto A. Toll-like receptors' pathway disturbances are associated with increased susceptibility to infections in humans. Arch Immunol Ther Exp (Warsz) 2013, 61(6):427-443.
10. Orange J.S. Natural killer cell deficiency. J Allergy Clin Immunol 2013, 132(3):515-525. [quiz: 526].
11. Faitelson Y., Grunebaum E. Hemophagocytic lymphohistiocytosis and primary immune deficiency disorders. Clin Immunol 2014, 155(1):118-125.
12. Charbonnier L.M., Janssen E., Chou J., et al. Regulatory T-cell deficiency and immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like disorder caused by loss-of-function mutations in LRBA. J Allergy Clin Immunol 2015, 135(1):217-227.
13. Verbsky J.W., Chatila T.A. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disorders: an evolving web of heritable autoimmune diseases. Curr Opin Pediatr 2013, 25(6):708-714.
14. Veillette A., Perez-Quintero L.A., Latour S. X-linked lymphoproliferative syndromes and related autosomal recessive disorders. Curr Opin Allergy Clin Immunol 2013, 13(6):614-622.
15. Lohr N.J., Molleston J.P., Strauss K.A., et al. Human ITCH E3 ubiquitin ligase deficiency causes syndromic multisystem autoimmune disease. Am J Hum Genet 2010, 86(3):447-453.
16. Oliveira J.B., Bleesing J.J., Dianzani U., et al. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop. Blood 2010, 116(14):e35-e40.
17. Rigante D., Vitale A., Lucherini O.M., et al. The hereditary autoinflammatory disorders uncovered. Autoimmun Rev 2014, 13(9):892-900.
18. Locke B.A., Dasu T., Verbsky J.W. Laboratory diagnosis of primary immunodeficiencies. Clin Rev Allergy Immunol 2014, 46(2):154-168.
19. Berger M. Choices in IgG replacement therapy for primary immune deficiency diseases: subcutaneous IgG vs. intravenous IgG and selecting an optimal dose. Curr Opin Allergy Clin Immunol 2011, 11(6):532-538.
20. Verbsky J.W., Routes J.M. Sarcoidosis and common variable immunodeficiency: similarities and differences. Semin Respir Crit Care Med 2014, 35(3):330-335.
21. Wehr C., Gennery A.R., Lindemans C., et al. Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency. J Allergy Clin Immunol 2015, 135(4):988-997.e6.
22. Farinelli G., Capo V., Scaramuzza S., et al. Lentiviral vectors for the treatment of primary immunodeficiencies. J Inherit Metab Dis 2014, 37(4):525-533.
23. Pai S.Y., Logan B.R., Griffith L.M., et al. Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med 2014, 371(5):434-446.
24. de la Morena M.T., Nelson R.P. Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review. Clin Rev Allergy Immunol 2014, 46(2):131-144.
25. Jyonouchi S., McDonald-McGinn D.M., Bale S., et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics 2009, 123(5):e871-e877.
26. Gennery A.R. Immunological aspects of 22q11.2 deletion syndrome. Cell Mol Life Sci 2012, 69(1):17-27.
27. Stiehm R.E., Ochs H.D., Winkelstein J.A. Immunodeficiency disorders: general considerations 2004, Saunders, Philadelphia (PA). 5th edition.
28. Driessen G., van der Burg M. Educational paper: primary antibody deficiencies. Eur J Pediatr 2011, 170(6):693-702.
29. Winkelstein J.A., Marino M.C., Lederman H.M., et al. X-linked agammaglobulinemia: report on a United States registry of 201 patients. Medicine (Baltimore) 2006, 85(4):193-202.
30. Cunningham-Rundles C. The many faces of common variable immunodeficiency. Hematol Am Soc Hematol Educ Program 2012, 2012:301-305.
31. Qamar N., Fuleihan R.L. The hyper IgM syndromes. Clin Rev Allergy Immunol 2014, 46(2):120-130.
32. Winkelstein J.A., Marino M.C., Ochs H., et al. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Medicine (Baltimore) 2003, 82(6):373-384.
33. Crank M.C., Grossman J.K., Moir S., et al. Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol 2014, 34(3):272-276.
34. Picard C., Dogniaux S., Chemin K., et al. Hypomorphic mutation of ZAP70 in human results in a late onset immunodeficiency and no autoimmunity. Eur J Immunol 2009, 39(7):1966-1976.
35. de la Calle-Martin O., Hernandez M., Ordi J., et al. Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 2001, 108(1):117-123.
36. Zimmer J., Andres E., Donato L., et al. Clinical and immunological aspects of HLA class I deficiency. QJM 2005, 98(10):719-727.
37. Reith W., Mach B. The bare lymphocyte syndrome and the regulation of MHC expression. Annu Rev Immunol 2001, 19:331-373.
38. Li F.Y., Lenardo M.J., Chaigne-Delalande B. Loss of MAGT1 abrogates the Mg2+ flux required for T cell signaling and leads to a novel human primary immunodeficiency. Magnesium Res 2011, 24(3):S109-S114.
39. Hauck F., Randriamampita C., Martin E., et al. Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency. J Allergy Clin Immunol 2012, 130(5):1144-1152.e11.
40. Lopez-Herrera G., Tampella G., Pan-Hammarstrom Q., et al. Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity. Am J Hum Genet 2012, 90(6):986-1001.
41. Gorska M.M., Alam R. A mutation in the human Uncoordinated 119 gene impairs TCR signaling and is associated with CD4 lymphopenia. Blood 2012, 119(6):1399-1406.
42. van Montfrans J.M., Hoepelman A.I., Otto S., et al. CD27 deficiency is associated with combined immunodeficiency and persistent symptomatic EBV viremia. J Allergy Clin Immunol 2012, 129(3):787-793.e6.
43. Ghosh S., Bienemann K., Boztug K., et al. Interleukin-2-inducible T-cell kinase (ITK) deficiency - clinical and molecular aspects. J Clin Immunol 2014, 34(8):892-899.
44. Buchbinder D., Nugent D.J., Fillipovich A.H. Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments. Appl Clin Genet 2014, 7:55-66.
45. Lanzi G., Moratto D., Vairo D., et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J Exp Med 2012, 209(1):29-34.
46. O'Driscoll M. Diseases associated with defective responses to DNA damage. Cold Spring Harb Perspect Biol 2012, 4(12). [pii:a012773].
47. Baradaran-Heravi A., Thiel C., Rauch A., et al. Clinical and genetic distinction of Schimke immuno-osseous dysplasia and cartilage-hair hypoplasia. Am J Med Genet A 2008, 146A(15):2013-2017.
48. Farmand S., Sundin M. Hyper-IgE syndromes: recent advances in pathogenesis, diagnostics and clinical care. Curr Opin Hematol 2015, 22(1):12-22.
49. Etzioni A. Genetic etiologies of leukocyte adhesion defects. Curr Opin Immunol 2009, 21(5):481-486.
50. Hsu A.P., McReynolds L.J., Holland S.M. GATA2 deficiency. Curr Opin Allergy Clin Immunol 2015, 15(1):104-109.